Ben Greijdanus
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 17
- Antibiotics Pharmacokinetics and Efficacy 16
-
- Antifungal resistance and susceptibility 3
- Tuberculosis Research and Epidemiology 3
- Co-authors
- Jan‐Willem C. Alffenaar (25 shared papers)Donald R. A. Uges (20 shared papers)Remco A. Koster (13 shared papers)Hans Wynberg (4 shared papers)Daan J. Touw (11 shared papers)Jos G. W. Kosterink (7 shared papers)A. Mireille A. Wessels (5 shared papers)Kai van Hateren (7 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)Bioanalysis (5 papers)Therapeutic Drug Monitoring (4 papers)Journal of Chromatography B (4 papers)Talanta (3 papers)
- Partner nations
- NetherlandsVietnamUnited States
In The Last Decade
Ben Greijdanus
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 100
- Transplantation 82
- Pharmacology 396
- Toxicology 63
- Infectious Diseases 287
- Immunology 326
Countries citing papers authored by Ben Greijdanus
This map shows the geographic impact of Ben Greijdanus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Greijdanus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Greijdanus more than expected).
Fields of papers citing papers by Ben Greijdanus
This network shows the impact of papers produced by Ben Greijdanus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Greijdanus. The network helps show where Ben Greijdanus may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben Greijdanus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 111 | |
| 2 | 2009 | 81 | |
| 3 | 1978 | 73 | |
| 4 | 2014 | 69 | |
| 5 | 2012 | 68 | |
| 6 | 2015 | 62 | |
| 7 | 2009 | 53 | |
| 8 | 1982 | 53 | |
| 9 | 2013 | 49 | |
| 10 | 2014 | 47 | |
| 11 | 2010 | 45 | |
| 12 | 2015 | 39 | |
| 13 | 2013 | 38 | |
| 14 | 2005 | 35 | |
| 15 | 2014 | 34 | |
| 16 | 2013 | 31 | |
| 17 | 2015 | 29 | |
| 18 | 2013 | 28 | |
| 19 | 2013 | 25 | |
| 20 | 2012 | 22 |
About Ben Greijdanus
Ben Greijdanus is a scholar working on Pharmacology, Infectious Diseases, Epidemiology, Immunology and Hematology, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Biosimilars and Bioanalytical Methods (9 papers), Erythropoietin and Anemia Treatment (4 papers), Clinical Laboratory Practices and Quality Control (3 papers), Antifungal resistance and susceptibility (3 papers), Tuberculosis Research and Epidemiology (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Mycobacterium research and diagnosis (3 papers). The work is most often cited by research in Transplantation (82 citations), Pharmacology (396 citations), Toxicology (63 citations), Infectious Diseases (287 citations) and Immunology (326 citations). Ben Greijdanus has collaborated with scholars based in Netherlands, Vietnam and United States. Frequent co-authors include Jan‐Willem C. Alffenaar, Donald R. A. Uges, Remco A. Koster, Hans Wynberg, Daan J. Touw, Jos G. W. Kosterink, A. Mireille A. Wessels, Kai van Hateren, Mathieu S. Bolhuis and Dinh Hoa Vu. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Bioanalysis, Therapeutic Drug Monitoring, Journal of Chromatography B and Talanta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.